{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:36Z","timestamp":1791118776127,"version":"4.1.0"},"reference-count":210,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,2,1]]},"DOI":"10.1210\/edrv.18.1.0288","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T18:26:43Z","timestamp":1389205603000},"page":"135-156","source":"Crossref","is-referenced-by-count":47,"title":["11\u03b2-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*"],"prefix":"10.1210","volume":"18","author":[{"given":"Perrin C.","family":"White","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas Texas 75235-9063"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoatsu","family":"Mune","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas Texas 75235-9063"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas Texas 75235-9063"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041121545954400_R1","first-page":"577","article-title":"Steroid 5 alpha-reductase 2 deficiency.","volume":"14","author":"Wilson","year":"1993","journal-title":"Endocr Rev"},{"key":"2019041121545954400_R2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.1950.02920160001001","article-title":"Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases.","volume":"144","author":"Hench","year":"1950","journal-title":"J Am Med Assoc"},{"key":"2019041121545954400_R3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/jama.1951.02920190010003","article-title":"Oral use of cortisone acetate.","volume":"145","author":"Boland","year":"1996","journal-title":"J Am Med Assoc"},{"key":"2019041121545954400_R4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.1951.03670340019005","article-title":"Hydrocortisone and cortisone injected into arthritic joints. Comparative effects of and use of hydrocortisone as a local antiarthritic agent.","volume":"147","author":"Hollander","year":"1951","journal-title":"J Am Med Assoc"},{"key":"2019041121545954400_R5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9258(18)56535-2","article-title":"Isolation of adrenal cortical hormones from urine: 17-hydroxycorticosterone and 17-hydroxy-11-dehydrocorticosterone.","volume":"182","author":"Mason","year":"1950","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jcem-13-9-1125","article-title":"Conversion of cortisone to compound F.","volume":"13","author":"Amelung","year":"1953","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0021-9258(18)65275-5","article-title":"Substrate specificity of enzymes reducing the 11- and 20-keto groups of steroids.","volume":"220","author":"Hubener","year":"1956","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2265.1981.tb00616.x","article-title":"Human corticosteroid binding globulin.","volume":"14","author":"Brien","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R9","first-page":"647","article-title":"Synthesis and metabolism of corticosteroids","author":"White","year":"1995","journal-title":"In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Lippincott, Philadelphia, pp"},{"key":"2019041121545954400_R10","first-page":"410","article-title":"Clinical aspects of steroid conjugation","author":"Bongiovanni","year":"1970","journal-title":"In: Bernstein S, Solomon S (eds) Chemical and Biological Aspects of Steroid Conjugation. Springer-Verlag, New York, pp"},{"key":"2019041121545954400_R11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00240294","article-title":"Regulation of renal epithellial sodium channels.","volume":"114","author":"Duchatelle","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"2019041121545954400_R12","first-page":"37","article-title":"Regulation of apical membrane Na and K channels in rat renal collecting tubules by aldosterone.","volume":"12","author":"Palmer","year":"1992","journal-title":"Semin Nephrol"},{"key":"2019041121545954400_R13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.19.3.221","article-title":"Aldosterone regulation of gene transcription leading to control of ion transport.","volume":"19","author":"Horisberger","year":"1992","journal-title":"Hypertension"},{"key":"2019041121545954400_R14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0039-128X(94)00027-A","article-title":"Nongenomic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action.","volume":"60","author":"Wehling","year":"1995","journal-title":"Steroids"},{"key":"2019041121545954400_R15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"2019041121545954400_R16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.8382376","article-title":"Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element.","volume":"259","author":"Pearce","year":"1993","journal-title":"Science"},{"key":"2019041121545954400_R17","first-page":"1226","article-title":"Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy.","volume":"7","author":"Robertson","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2019041121545954400_R18","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity.","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121545954400_R19","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1210\/endo-113-6-2043","article-title":"Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.","volume":"113","author":"Beaumont","year":"1983","journal-title":"Endocrinology"},{"key":"2019041121545954400_R20","first-page":"F227","article-title":"Extravascular CBG-like sites in rat kidney and mineralocorticoid receptor specificity","volume":"246","author":"Stephenson","year":"1984","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R21","first-page":"E224","article-title":"Mineralocorticoid specificity of renal type I receptors: in vivo binding studies","volume":"252","author":"Sheppard","year":"1987","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R22","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/endo.135.3.8070376","article-title":"The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 beta-hydroxysteroid dehydrogenase.","volume":"135","author":"Lombes","year":"1994","journal-title":"Endocrinology"},{"key":"2019041121545954400_R23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"2019041121545954400_R24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11 beta-hydroxysteroid dehydrogenase\u2013tissue specific protector of the mineralocorticoid receptor.","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"2019041121545954400_R25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"2019041121545954400_R26","first-page":"385","article-title":"Unusual steroid excretion in a child with low-renin hypertension.","volume":"6","author":"Werder","year":"1974","journal-title":"Res Steroids"},{"key":"2019041121545954400_R27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-44-5-924","article-title":"Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.","volume":"44","author":"New","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/jcem-44-4-799","article-title":"An abnormality in steroid reductive metabolism in a hypertensive syndrome.","volume":"44","author":"Ulick","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol.","volume":"49","author":"Ulick","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R30","first-page":"199","article-title":"A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion.","volume":"76","author":"Liddle","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"2019041121545954400_R31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","article-title":"Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the \u03b2 subunit of the epithelial sodium channel.","volume":"79","author":"Shimkets","year":"1994","journal-title":"Cell"},{"key":"2019041121545954400_R32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng0995-76","article-title":"Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.","volume":"11","author":"Hansson","year":"1995","journal-title":"Nat Genet"},{"key":"2019041121545954400_R33","first-page":"123","article-title":"A syndrome of low-renin hypertension in children","author":"Winter","year":"1977","journal-title":"In: New MI, Levine LS (eds) Juvenile Hypertension. Raven Press, New York, pp"},{"key":"2019041121545954400_R34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2265.1985.tb00160.x","article-title":"Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families.","volume":"22","author":"Shackleton","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1507\/endocrine1927.55.10_1341","article-title":"Studies on the metabolic abnormality of cortisol and corticosterone in a case of dexamethasone responsive mineralocorticoid excess.","volume":"55","author":"Igarashi","year":"1979","journal-title":"Folia Endocrinol Jpn"},{"key":"2019041121545954400_R36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jcem-50-4-786","article-title":"Hypertension in a four-year-old child:gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids.","volume":"50","author":"Shackleton","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000179490","article-title":"Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child.","volume":"16","author":"Fiselier","year":"1982","journal-title":"Horm Res"},{"key":"2019041121545954400_R38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/adc.58.12.1018","article-title":"Fatal, low renin hypertension associated with a disturbance of cortisol metabolism.","volume":"58","author":"Honour","year":"1983","journal-title":"Arch Dis Child"},{"key":"2019041121545954400_R39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.1984.tb01388.x","article-title":"Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.","volume":"21","author":"Harinck","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-63-3-550","article-title":"The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.","volume":"63","author":"Monder","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.1987.tb00838.x","article-title":"New findings in apparent mineralocorticoid excess.","volume":"27","author":"Dimartino-Nardi","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3476(86)80282-7","article-title":"Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome.","volume":"109","author":"Batista","year":"1986","journal-title":"J Pediatr"},{"key":"2019041121545954400_R43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.","volume":"82","author":"Stewart","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121545954400_R44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1995.tb01923.x","article-title":"Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of\u2019 apparent\u2019 mineralocorticoid excess.","volume":"43","author":"Milford","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R45","first-page":"2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.","volume":"80","author":"Wilson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"key":"2019041121545954400_R47","first-page":"3145","article-title":"Several homozygous mutations in the gene for 11\u03b2-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess.","volume":"80","author":"Wilson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2265.1996.677500.x","article-title":"Apparent mineralocorticoid excess due to 11\u03b2-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation.","volume":"44","author":"Kitanaka","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0022-4731(82)90062-0","article-title":"Partial characterization of unusual polar steroids in the urine of a child with low renin hypertension.","volume":"16","author":"Bournot","year":"1982","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1210\/jcem-56-2-332","article-title":"Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.","volume":"56","author":"Oberfield","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R51","first-page":"830","article-title":"Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.","volume":"78","author":"Riddle","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(91)90179-V","article-title":"Medicinal uses of licorice through the millennia: the good and plenty of it.","volume":"78","author":"Davis","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(53)91801-7","article-title":"Effects of liquorice and its derivatives on salt and water metabolism.","volume":"1","author":"Card","year":"1953","journal-title":"Lancet"},{"key":"2019041121545954400_R54","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jama.1968.03140330034006","article-title":"Licorice-induced pseudoaldosteronism, hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.","volume":"205","author":"Conn","year":"1968","journal-title":"J Am Med Assoc"},{"key":"2019041121545954400_R55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bmj.1.6055.209","article-title":"Liquorice toxicity and the renin-angiotensin-aldosterone axis in man.","volume":"1","author":"Epstein","year":"1977","journal-title":"Br Med J"},{"key":"2019041121545954400_R56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism.","volume":"325","author":"Farese Jr","year":"1991","journal-title":"N Engl J Med"},{"key":"2019041121545954400_R57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(53)91800-5","article-title":"Synergistic action of liquorice and cortisone in Addison\u2019s and Simmond\u2019s disease.","volume":"1","author":"Borst","year":"1953","journal-title":"Lancet"},{"key":"2019041121545954400_R58","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1210\/endo-129-5-2451","article-title":"The\u201c mineralocorticoid-like\u201d actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.","volume":"129","author":"Souness","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121545954400_R59","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jcem-70-6-1637","article-title":"The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers.","volume":"70","author":"Mac Kenzie","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R60","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1210\/endo-125-2-1046","article-title":"Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies.","volume":"125","author":"Monder","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121545954400_R61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ki.1990.258","article-title":"Inhibition of 11 beta-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport.","volume":"38","author":"Hierholzer","year":"1990","journal-title":"Kidney Int"},{"key":"2019041121545954400_R62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0039-128X(90)90024-6","article-title":"The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha- and 3 beta-hydroxysteroid dehydrogenases and 5 alpha- and 5 beta-reductase pathways of metabolism of aldosterone in male rats.","volume":"55","author":"Latif","year":"1990","journal-title":"Steroids"},{"key":"2019041121545954400_R63","first-page":"F756","article-title":"The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone","volume":"258","author":"Morris","year":"1990","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/cs0780049","article-title":"Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.","volume":"78","author":"Stewart","year":"1990","journal-title":"Clin Sci"},{"key":"2019041121545954400_R65","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1210\/endo.136.4.7895688","article-title":"Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo.","volume":"136","author":"Escher","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0960-0760(94)90304-2","article-title":"Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds.","volume":"49","author":"Zhang","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R67","first-page":"792","article-title":"Inhibition of 11 beta-hydroxysteroid dehydrogenase by gossypol and bioflavonoids.","volume":"120","author":"Song","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2019041121545954400_R68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0009-9236(96)90025-9","article-title":"Grapefruit juice and its flavonoids inhibit 11\u03b2-hydroxysteroid dehydrogenase.","volume":"59","author":"Lee","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"2019041121545954400_R69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.1992.tb01478.x","article-title":"Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.","volume":"37","author":"Walker","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R70","first-page":"963","article-title":"Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome.","volume":"74","author":"Ulick","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/eje.0.1340301","article-title":"Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?","volume":"134","author":"Diederich","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2019041121545954400_R72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.705336","article-title":"Prenatal exposure to prednisone in humans and animals retards intrauterine growth.","volume":"202","author":"Reinisch","year":"1978","journal-title":"Science"},{"key":"2019041121545954400_R73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0140-6736(93)90148-A","article-title":"Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension?","volume":"341","author":"Edwards","year":"1993","journal-title":"Lancet"},{"key":"2019041121545954400_R74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0140-6736(93)90138-7","article-title":"Glucocorticoid exposure in utero: new model for adult hypertension.","volume":"341","author":"Benediktsson","year":"1993","journal-title":"Lancet"},{"key":"2019041121545954400_R75","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/adc.66.11.1291","article-title":"Maternal and fetal influences on blood pressure.","volume":"66","author":"Law","year":"1991","journal-title":"Arch Dis Child"},{"key":"2019041121545954400_R76","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.","volume":"298","author":"Barker","year":"1989","journal-title":"Br Med J"},{"key":"2019041121545954400_R77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.301.6746.259","article-title":"Fetal and placental size and risk of hypertension in adult life.","volume":"301","author":"Barker","year":"1990","journal-title":"Br Med J"},{"key":"2019041121545954400_R78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.306.6869.24","article-title":"Initiation of hypertension in utero and its amplification throughout life.","volume":"306","author":"Law","year":"1993","journal-title":"Br Med J"},{"key":"2019041121545954400_R79","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","article-title":"Fetal nutrition and cardiovascular disease in adult life.","volume":"341","author":"Barker","year":"1993","journal-title":"Lancet"},{"key":"2019041121545954400_R80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/bmj.308.6924.298","article-title":"Blood pressure in prospective population based cohort of newborn and infant twins.","volume":"308","author":"Levine","year":"1994","journal-title":"Br Med J"},{"key":"2019041121545954400_R81","first-page":"885","article-title":"Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis.","volume":"80","author":"Stewart","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R82","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.20.3.356","article-title":"Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.","volume":"20","author":"Morris","year":"1992","journal-title":"Hypertension"},{"key":"2019041121545954400_R83","first-page":"529","article-title":"Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension.","volume":"80","author":"Walker","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.HYP.27.2.197","article-title":"Endogenous renal 11\u03b2-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.","volume":"27","author":"Takeda","year":"1996","journal-title":"Hypertension"},{"key":"2019041121545954400_R85","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1210\/endo.136.4.7895695","article-title":"11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat.","volume":"136","author":"Souness","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.25.1.67","article-title":"Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension.","volume":"25","author":"Soro","year":"1995","journal-title":"Hypertension"},{"key":"2019041121545954400_R87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1993.tb01778.x","article-title":"Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension.","volume":"39","author":"Walker","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R88","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0039-128X(94)90022-1","article-title":"The activities of 5 beta-reductase and 11 beta-hydroxysteroid dehydrogenase in essential hypertension.","volume":"59","author":"Iki","year":"1994","journal-title":"Steroids"},{"key":"2019041121545954400_R89","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0895-7061(95)00021-G","article-title":"Cortisol metabolism in hypertensive patients who do and do not develop hypokalemia from diuretics.","volume":"8","author":"Santini","year":"1995","journal-title":"Am J Hypertens"},{"key":"2019041121545954400_R90","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.HYP.27.2.190","article-title":"Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension.","volume":"27","author":"Walker","year":"1996","journal-title":"Hypertension"},{"key":"2019041121545954400_R91","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0022-4731(85)90451-0","article-title":"A new defect in the peripheral conversion of cortisone to cortisol.","volume":"22","author":"Phillipou","year":"1985","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R92","first-page":"687","article-title":"Defects in the HSD11 gene encoding 11\u03b2-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.","volume":"77","author":"Nikkila","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R92A","first-page":"3855","volume":"81","author":"Phillipov","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/jcem-43-2-265","article-title":"Unusual low plasma renin hypertension in a child.","volume":"43","author":"Sann","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jcem-70-1-200","article-title":"Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.","volume":"70","author":"Ulick","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(89)90166-0","article-title":"A new form of the syndrome of apparent mineralocorticoid excess.","volume":"32","author":"Ulick","year":"1989","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R96","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0039-128X(94)90080-9","article-title":"Apparent mineralocorticoid excess type II.","volume":"59","author":"Mantero","year":"1994","journal-title":"Steroids"},{"key":"2019041121545954400_R97","first-page":"593","article-title":"Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess.","volume":"74","author":"Ulick","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0083-6729(08)60447-1","article-title":"11 Beta-hydroxysteroid dehydrogenase.","volume":"47","author":"Monder","year":"1993","journal-title":"Vitam Horm"},{"key":"2019041121545954400_R99","first-page":"3155","article-title":"Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.","volume":"80","author":"Walker","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R100","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/endo-123-5-2390","article-title":"Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex.","volume":"123","author":"Lakshmi","year":"1988","journal-title":"Endocrinology"},{"key":"2019041121545954400_R101","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2265.1989.tb01259.x","article-title":"The kidney is the major site of cortisone production in man.","volume":"31","author":"Whitworth","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R102","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1172\/JCI114781","article-title":"Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.","volume":"86","author":"Bonvalet","year":"1990","journal-title":"J Clin Invest"},{"key":"2019041121545954400_R103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/endo-129-1-17","article-title":"11 beta-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone.","volume":"129","author":"Naray-Fejes-Toth","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121545954400_R104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0039-128X(94)90084-1","article-title":"Expression of 11 beta-OHSD along the nephron of mammals and humans.","volume":"59","author":"Kenouch","year":"1994","journal-title":"Steroids"},{"key":"2019041121545954400_R105","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1016\/S0021-9258(18)82044-0","article-title":"A new isoform of 11 beta-hydroxysteroid dehydrogenase in aldosterone target cells.","volume":"268","author":"Rusvai","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R106","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0167-4889(89)90054-2","article-title":"Renal epithelial cell lines (BSC-1, MDCK, LLC-PK1) express 11 beta-hydroxysteroid dehydrogenase activity.","volume":"1010","author":"Korbmacher","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"2019041121545954400_R107","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1210\/endo.136.12.7588309","article-title":"LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.","volume":"136","author":"Leckie","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R108","first-page":"627","article-title":"Inactivation of corticosteroids in intestinal mucosa by 11 beta-hydroxysteroid: NADP oxidoreductase (EC 1.1.1.146).","volume":"78","author":"Burton","year":"1983","journal-title":"Am J Gastroenterol"},{"key":"2019041121545954400_R109","first-page":"E951","article-title":"11 Beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in the rat colon","volume":"264","author":"Whorwood","year":"1993","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R110","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1210\/endo-127-3-1450","article-title":"11 Beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex.","volume":"127","author":"Moisan","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121545954400_R111","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo-128-4-1741","article-title":"Regional distribution of 11 beta-hydroxysteroid dehydrogenase in rat brain.","volume":"128","author":"Lakshmi","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121545954400_R112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1523\/JNEUROSCI.16-01-00065.1996","article-title":"11\u03b2-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity.","volume":"16","author":"Rajan","year":"1996","journal-title":"J Neurosci"},{"key":"2019041121545954400_R113","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1152\/physrev.1986.66.4.1121","article-title":"Adrenal steroid receptors and action in the nervous system.","volume":"66","author":"McEwen","year":"1986","journal-title":"Physiol Rev"},{"key":"2019041121545954400_R114","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0896-6273(88)90136-5","article-title":"The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response.","volume":"1","author":"Arriza","year":"1988","journal-title":"Neuron"},{"key":"2019041121545954400_R115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ajh\/4.4.374","article-title":"What is the role of the central nervous system in mineralocorticoid hypertension?","volume":"4","author":"Gomez Sanchez","year":"1991","journal-title":"Am J Hypertens"},{"key":"2019041121545954400_R116","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-62-2-275","article-title":"Multiple factors contribute to the pathogenesis of hypertension in Cushing\u2019s syndrome.","volume":"62","author":"Saruta","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-4731(82)90173-X","article-title":"Studies of high affinity binding of mineralo- and glucocorticoids in rabbit aorta cytosol.","volume":"16","author":"Kornel","year":"1982","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R118","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","article-title":"Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.","volume":"125","author":"Funder","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121545954400_R119","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ajh\/7.1.100","article-title":"Colocalization of 11 beta-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells.","volume":"7","author":"Kornel","year":"1994","journal-title":"Am J Hypertens"},{"key":"2019041121545954400_R120","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","article-title":"11 Beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.","volume":"129","author":"Walker","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121545954400_R121","first-page":"970","article-title":"Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.","volume":"131","author":"Walker","year":"1992","journal-title":"Endocrinology"},{"key":"2019041121545954400_R122","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.HYP.23.5.577","article-title":"Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats.","volume":"23","author":"Takeda","year":"1994","journal-title":"Hypertension"},{"key":"2019041121545954400_R123","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"2019041121545954400_R124","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension, and cardiac fibrosis.","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121545954400_R125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart.","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"key":"2019041121545954400_R126","first-page":"1334","article-title":"Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase.","volume":"79","author":"Kenouch","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jcem-73-2-326","article-title":"Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action.","volume":"73","author":"Hammami","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R128","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0140-6736(90)92633-S","article-title":"Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.","volume":"335","author":"Teelucksingh","year":"1990","journal-title":"Lancet"},{"key":"2019041121545954400_R129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/joe.0.1350053","article-title":"11 beta-Hydroxysteroid dehydrogenase in the rat ovary: high expression in the oocyte.","volume":"135","author":"Benediktsson","year":"1992","journal-title":"J Endocrinol"},{"key":"2019041121545954400_R130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0140-6736(93)91710-4","article-title":"Ovarian 11 beta-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilisation and embryo transfer.","volume":"342","author":"Michael","year":"1993","journal-title":"Lancet"},{"key":"2019041121545954400_R131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0015-0282(16)57798-X","article-title":"Ovarian 11 beta-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilization-embryo transfer treatment cycles.","volume":"64","author":"Michael","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041121545954400_R132","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2265.1993.tb02147.x","article-title":"Direct inhibition of ovarian steroidogenesis by cortisol and the modulatory role of 11 beta-hydroxysteroid dehydrogenase.","volume":"38","author":"Michael","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121545954400_R133","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1203\/00006450-197305000-00004","article-title":"The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term.","volume":"7","author":"Beitins","year":"1973","journal-title":"Pediatr Res"},{"key":"2019041121545954400_R134","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9378(16)33697-3","article-title":"Conversion of maternal cortisol to cortisone during placental transfer to the human fetus.","volume":"118","author":"Murphy","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121545954400_R135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/endo.137.2.8593807","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase during decidualization of human endometrial stromal cells.","volume":"137","author":"Arcuri","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121545954400_R136","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/endo.133.3.8365358","article-title":"Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence.","volume":"133","author":"Guller","year":"1993","journal-title":"Endocrinology"},{"key":"2019041121545954400_R137","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0960-0760(93)90008-K","article-title":"Characterization of 11 beta-hydroxysteroid dehydrogenase of human placenta: evidence for the existence of two species of 11 beta-hydroxysteroid dehydrogenase.","volume":"45","author":"Lakshmi","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R138","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1210\/endo.132.6.8504762","article-title":"Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform.","volume":"132","author":"Brown","year":"1993","journal-title":"Endocrinology"},{"key":"2019041121545954400_R139","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0039-128X(95)00201-Z","article-title":"11\u03b2-Hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances.","volume":"61","author":"Gomez-Sanchez","year":"1996","journal-title":"Steroids"},{"key":"2019041121545954400_R140","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/endo-126-5-2742","article-title":"Regulation of 11 beta-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen.","volume":"126","author":"Baggia","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121545954400_R141","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/endo-127-4-1735","article-title":"Interconversion of cortisol and cortisone in baboon trophoblast and decidua cells in culture.","volume":"127","author":"Baggia","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121545954400_R142","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0022-4731(81)90226-0","article-title":"Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development.","volume":"14","author":"Murphy","year":"1981","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R143","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0039-128X(73)90007-X","article-title":"The growth promoting effect of cortisol on human fetal lung cells.","volume":"22","author":"Smith","year":"1973","journal-title":"Steroids"},{"key":"2019041121545954400_R144","doi-asserted-by":"crossref","first-page":"C173","DOI":"10.1152\/ajpcell.1985.249.1.C173","article-title":"Compartmentalization of 11-oxidoreductase within fetal lung alveolus","volume":"249","author":"Torday","year":"1985","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0022-4731(85)90435-2","article-title":"Extraction of 11 beta-hydroxysteroid dehydrogenase from rat liver microsomes by detergents.","volume":"22","author":"Lakshmi","year":"1985","journal-title":"J Steroid Biochem"},{"key":"2019041121545954400_R146","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/endo-116-2-552","article-title":"Evidence for independent 11-oxidase and 11-reductase activities of 11 beta-hydroxysteroid dehydrogenase: enzyme latency, phase transitions, and lipid requirements.","volume":"116","author":"Lakshmi","year":"1985","journal-title":"Endocrinology"},{"key":"2019041121545954400_R147","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1073\/pnas.88.22.10064","article-title":"Three-dimensional structure of holo 3 alpha,20 beta-hydroxysteroid dehydrogenase: a member of a short-chain dehydrogenase family.","volume":"88","author":"Ghosh","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121545954400_R148","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1074\/jbc.270.5.2305","article-title":"Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase.","volume":"270","author":"Ozols","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R149","doi-asserted-by":"crossref","first-page":"18939","DOI":"10.1016\/S0021-9258(19)47248-7","article-title":"Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.","volume":"264","author":"Agarwal","year":"1989","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R150","doi-asserted-by":"crossref","first-page":"16653","DOI":"10.1016\/S0021-9258(18)55351-5","article-title":"The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization.","volume":"266","author":"Tannin","year":"1991","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0960-0760(94)00159-J","article-title":"Cloning, sequencing and tissue-distribution of mouse 11 beta-hydroxysteroid dehydrogenase-1 cDNA.","volume":"52","author":"Rajan","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R152","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1210\/endo.131.5.1425412","article-title":"Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development.","volume":"131","author":"Yang","year":"1992","journal-title":"Endocrinology"},{"key":"2019041121545954400_R153","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1210\/endo.133.1.8319583","article-title":"Structure and function of the hepatic form of 11 beta-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance.","volume":"133","author":"Moore","year":"1993","journal-title":"Endocrinology"},{"key":"2019041121545954400_R154","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1432-1033.1991.tb16215.x","article-title":"Characteristics of short-chain alcohol dehydrogenases and related enzymes.","volume":"200","author":"Persson","year":"1991","journal-title":"Eur J Biochem"},{"key":"2019041121545954400_R155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0006-291X(92)92373-6","article-title":"Tyr-179 and Lys-183 are essential for enzymatic activity of 11 beta-hydroxysteroid dehydrogenase.","volume":"188","author":"Obeid","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121545954400_R156","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-291X(05)80262-1","article-title":"Site-directed mutagenesis of the conserved tyrosine-151 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme.","volume":"176","author":"Ensor","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121545954400_R157","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/bi00064a017","article-title":"Site-specific mutagenesis of Drosophila alcohol dehydrogenase: evidence for involvement of tyrosine-152 and lysine-156 in catalysis.","volume":"32","author":"Chen","year":"1993","journal-title":"Biochemistry"},{"key":"2019041121545954400_R158","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0960-0760(92)90093-X","article-title":"Inhibition of Streptomyces hydrogenans 3 alpha,20 beta-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex.","volume":"42","author":"Ghosh","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R159","first-page":"154","article-title":"Transcripts originating in intron 1 of the HSD11 (11 beta-hydroxysteroid dehydrogenase) gene encode a truncated polypeptide that is enzymatically inactive.","volume":"7","author":"Obeid","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2019041121545954400_R160","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/mend-4-12-1827","article-title":"Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus.","volume":"4","author":"Agarwal","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2019041121545954400_R161","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1677\/jme.0.0130167","article-title":"\u2019Liver-type\u2019 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells.","volume":"13","author":"Low","year":"1994","journal-title":"J Mol Endocrinol"},{"key":"2019041121545954400_R162","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/endo.132.2.8425481","article-title":"Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line.","volume":"132","author":"Duperrex","year":"1993","journal-title":"Endocrinology"},{"key":"2019041121545954400_R163","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0167-4838(95)00005-F","article-title":"Mutations in putative glycosylation sites of rat 11 beta-hydroxysteroid dehydrogenase affect enzymatic activity.","volume":"1248","author":"Agarwal","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"2019041121545954400_R164","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1210\/endo-127-6-3009","article-title":"Characterization of 11 beta-hydroxysteroid dehydrogenase gene expression: identification of multiple unique forms of messenger ribonucleic acid in the rat kidney.","volume":"127","author":"Krozowski","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121545954400_R165","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/endo-126-5-2435","article-title":"Corticosteroid 11 beta-dehydrogenase of rat tissues: immunological studies.","volume":"126","author":"Monder","year":"1990","journal-title":"Endocrinology"},{"key":"2019041121545954400_R166","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0960-0760(92)90220-D","article-title":"Tissue localization of 11 beta-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor.","volume":"41","author":"Whorwood","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R167","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/S0021-9258(18)45918-2","article-title":"Tissue-specific expression of an 11 beta-hydroxysteroid dehydrogenase with a truncated N-terminal domain. A potential mechanism for differential intracellular localization within mineralocorticoid target cells.","volume":"267","author":"Krozowski","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R168","first-page":"1082","article-title":"Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene.","volume":"6","author":"Moisan","year":"1992","journal-title":"Mol Endocrinol"},{"key":"2019041121545954400_R169","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0303-7207(93)90015-C","article-title":"Characterization of 11 beta-HSD1B gene expression and enzymatic activity.","volume":"92","author":"Mercer","year":"1993","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R170","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1210\/endo-125-3-1700","article-title":"The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies.","volume":"125","author":"Rundle","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121545954400_R171","first-page":"320","article-title":"Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with monoclonal antibody.","volume":"12","author":"Castello","year":"1989","journal-title":"Renal Physiol Biochem"},{"key":"2019041121545954400_R172","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/endo-128-4-2129","article-title":"Localization of renal 11 beta-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor.","volume":"128","author":"Stewart","year":"1991","journal-title":"Endocrinology"},{"key":"2019041121545954400_R173","first-page":"F764","article-title":"11 beta-Hydroxysteroid dehydrogenase mRNA expression in rat kidney","volume":"260","author":"Yau","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R174","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1210\/endo-125-1-209","article-title":"Corticosteroid 11 beta-dehydrogenase in rat testis.","volume":"125","author":"Phillips","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121545954400_R175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1677\/joe.0.1430541","article-title":"Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns.","volume":"143","author":"Low","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041121545954400_R176","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0303-7207(95)03501-W","article-title":"Sex- and tissue-specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA.","volume":"109","author":"Albiston","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R177","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/joe.0.1390027","article-title":"Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney.","volume":"139","author":"Low","year":"1993","journal-title":"J Endocrinol"},{"key":"2019041121545954400_R178","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.0.1430121","article-title":"Opposite effects of glucocorticoid on hepatic 11 beta-hydroxysteroid dehydrogenase mRNA and activity in fetal and adult sheep.","volume":"143","author":"Yang","year":"1994","journal-title":"J Endocrinol"},{"key":"2019041121545954400_R179","first-page":"L464","article-title":"11 beta-hydroxysteroid dehydrogenase activity in human lung cells and transcription regulation by glucocorticoids","volume":"267","author":"Page","year":"1994","journal-title":"Am J Physiol"},{"key":"2019041121545954400_R180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/endo.130.1.1727721","article-title":"Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney.","volume":"130","author":"Mercer","year":"1992","journal-title":"Endocrinology"},{"key":"2019041121545954400_R181","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0960-0760(94)90016-7","article-title":"Evidence for distinct isoforms of 11-beta-hydroxysteroid dehydrogenase in the ovine liver and kidney.","volume":"49","author":"Yang","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121545954400_R182","first-page":"1529","article-title":"Type 2 11beta-hydroxysteroid dehydrogenase in human fetal tissues.","volume":"78","author":"Stewart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R183","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1042\/bj3130997","article-title":"Purification of 11\u03b2-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique.","volume":"313","author":"Brown","year":"1996","journal-title":"Biochem J"},{"key":"2019041121545954400_R184","doi-asserted-by":"crossref","first-page":"25959","DOI":"10.1016\/S0021-9258(18)47142-6","article-title":"NAD+-dependent isoform of 11 beta hydroxysteroid dehydrogenase:cloning and characterization of cDNA from sheep kidney.","volume":"269","author":"Agarwal","year":"1994","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R185","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11-HSD type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R186","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/endo.136.6.7750480","article-title":"Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells.","volume":"136","author":"Naray-Fejes-Toth","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R187","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1210\/endo.136.9.7649078","article-title":"Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11 beta-hydroxysteroid dehydrogenase.","volume":"136","author":"Zhou","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R188","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/endo.136.10.7664690","article-title":"Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney.","volume":"136","author":"Cole","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R189","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.1016\/S0021-9258(18)31480-7","article-title":"Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity.","volume":"268","author":"Wu","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/geno.1995.1231","article-title":"Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11\u03b2-hydroxysteroid dehydrogenase.","volume":"29","author":"Agarwal","year":"1995","journal-title":"Genomics"},{"key":"2019041121545954400_R191","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0303-7207(96)03855-5","article-title":"Analysis of the promoter of the NAD+ dependent 11\u03b2-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells.","volume":"121","author":"Agarwal","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R192","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1172\/JCI117569","article-title":"17-HSD type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.","volume":"94","author":"Casey","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121545954400_R193","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(95)03559-P","article-title":"Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies","volume":"111","author":"Roland","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R194","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0303-7207(95)03546-J","article-title":"Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts","volume":"110","author":"Whorwood","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R195","first-page":"2203","article-title":"Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta.","volume":"80","author":"Krozowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R196","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ki.1996.39","article-title":"Immunolocalization of NAD-dependent 11\u03b2-hydroxysteroid dehydrogenase in human kidney and colon.","volume":"49","author":"Kyossev","year":"1996","journal-title":"Kidney Int"},{"key":"2019041121545954400_R197","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1210\/endo.137.3.8603583","article-title":"Localization of 11\u03b2-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies.","volume":"137","author":"Roland","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121545954400_R198","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1016\/0303-7207(95)03574-Q","article-title":"Cellular localization of 11 beta-hydroxysteroid dehydrogenase 2 gene expression in the ovine adrenal gland","volume":"111","author":"Yang","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121545954400_R199","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1210\/endo.136.10.7664691","article-title":"Hybridization histochemical localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat brain.","volume":"136","author":"Roland","year":"1995","journal-title":"Endocrinology"},{"key":"2019041121545954400_R200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/endo.137.2.8593833","article-title":"The ontogeny of 11\u03b2-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development.","volume":"137","author":"Brown","year":"1996","journal-title":"Endocrinology"},{"key":"2019041121545954400_R201","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","article-title":"Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11\u03b2-hydroxysteroid dehydrogenase type 2 gene.","volume":"347","author":"Stewart","year":"1996","journal-title":"Lancet"},{"key":"2019041121545954400_R202","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.HYP.27.6.1193","article-title":"Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype.","volume":"27","author":"Mune","year":"1996","journal-title":"Hypertension"},{"key":"2019041121545954400_R203","doi-asserted-by":"crossref","first-page":"I122","DOI":"10.1161\/01.HYP.17.1_Suppl.I122","article-title":"Biohistory of slavery and blood pressure differences in blacks today: a hypothesis","volume":"17","author":"Wilson","year":"1991","journal-title":"Hypertension"},{"key":"2019041121545954400_R204","first-page":"3381","article-title":"The R337C mutation generates a high Km 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess.","volume":"80","author":"Obeyesekere","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121545954400_R205","doi-asserted-by":"crossref","first-page":"20916","DOI":"10.1016\/S0021-9258(17)45304-X","article-title":"Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus.","volume":"265","author":"Tusie-Luna","year":"1990","journal-title":"J Biol Chem"},{"key":"2019041121545954400_R206","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1139\/o94-075","article-title":"Expression of the mdr1 P-glycoprotein gene: a mechanism of escape from glucocorticoid-induced apoptosis.","volume":"72","author":"Gruol","year":"1994","journal-title":"Biochem Cell Biol"},{"key":"2019041121545954400_R207","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"2019041121545954400_R208","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1073\/pnas.92.19.8545","article-title":"Genetic determinants of human hypertension.","volume":"92","author":"Lifton","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121545954400_R209","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1073\/pnas.91.9.3612","article-title":"Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.","volume":"91","author":"Smithies","year":"1994","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/18\/1\/135\/8860174\/edrv0135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:55:19Z","timestamp":1647910519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/18\/1\/135\/2530769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2,1]]},"references-count":210,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/edrv.18.1.0288","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2,1]]}}}